超越药物治疗:针对心力衰竭病理生理学的特定方面进行治疗的洞察
Camilla Normand1, David M Kaye2, Thomas J Povsic3
1Department of Cardiology, Stavanger University Hospital, Stavanger, Norway; Institute of Internal Medicine, University of Bergen, Bergen, Norway.
Lancet (London, England)
|March 13, 2019
概括
现在心力衰竭治疗的进展针对特定的病理生理机制. 新型疗法包括心脏再同步,阴道刺激,心房间间的分离和心肌再生的细胞疗法.
科学领域:
- 心脏病学
- 生物医学工程
- 复原医学
背景情况:
- 心力衰竭是一种普遍的疾病,具有显著的发病率和死亡率.
- 目前的治疗主要依赖于药物干预.
- 心力衰竭的复杂病理生理需要有针对性的治疗策略.
研究的目的:
- 介绍心力衰竭管理的最新进展.
- 突出具体解决潜在病理生理机制的治疗方法.
- 探索超越传统药物治疗的创新方法.
主要方法:
- 心脏再同步治疗和植入式心脏变压器用于电机失同和失节.
- 用于神经幽默调节的巴罗反射和神经刺激.
- 预防心脏重塑.
- 直接针对心肌和再生的细胞疗法.
主要成果:
- 针对性疗法在治疗特定心力衰竭机制方面已被证明有效.
- 成功应用基于器件的节奏和电导干预措施.
- 通过神经刺激和结构干预,
- 基于细胞的心肌修复方法的新兴潜力.
结论:
- 针对性治疗为治疗心力衰竭提供了新的途径,
- 结合基于设备,神经刺激,结构和再生策略的多面性方法显示出希望.
- 这些进展代表了对特定机制的心力衰竭治疗的重大转变.
相关概念视频
Pathophysiology of Heart Failure
3.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.4K
Heart Failure II: Pathophysiology
855
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
855
Heart Failure VI: Adjunct Therapies
313
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
313
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
611
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
611
Heart Failure I: Introduction
829
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
829
Heart Failure Drugs: Diuretics
935
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
935


